Tech Company Financing Transactions
Autonomic Technologies Funding Round
On 6/8/2016, Autonomic Technologies received $23 million in Series D investment from private investors.
Transaction Overview
Company Name
Announced On
6/8/2016
Transaction Type
Venture Equity
Amount
$23,045,640
Round
Series D
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 23 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
355 Ravendale Dr.
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Email Address
Overview
Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company's initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Niamh Pellegrini
Chief Financial Officer
Nicola Downes
VP - Marketing
Ashlea Mittelstaedt
VP - Operations
Ian Welsford
VP - Sales
Olivier Taelman
Browse more venture capital transactions:
Prev: 6/8/2016: ViZn Energy venture capital transaction
Next: 6/8/2016: Zinc venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. All VC database entries on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs